Literature DB >> 19128217

Experimental approaches to evaluate the thermodynamics of protein-drug interactions.

Walter Filgueira de Azevedo1, Raquel Dias.   

Abstract

Precise experimental methods to determine ligand-binding affinity are needed to accelerate the discovery of new drugs. Assessing protein-ligand interaction is of great importance for drug development. One of the techniques that may be used to evaluate ligand-binding affinitty is isothermal titration calorimetry (ITC). This experimental methodology may be used to measure the heat of binding of a ligand to a protein. Furthermore, the development of new empirical scoring functions to assess evaluation protein-ligand interaction lack abundance of experimental information to be used to generate reliable scores. ITC technique may be used to fill this gap. Here we describe the application of this technique to ligand-binding affinity determination, and discuss the synergetic relationship between ITC data and the development of a new generation of empirical scoring functions.

Mesh:

Substances:

Year:  2008        PMID: 19128217     DOI: 10.2174/138945008786949441

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  15 in total

1.  Reliable determinations of protein-ligand interactions by direct ESI-MS measurements. Are we there yet?

Authors:  Elena N Kitova; Amr El-Hawiet; Paul D Schnier; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2012-01-21       Impact factor: 3.109

2.  Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism.

Authors:  Shridhar Bale; Jean-Philippe Julien; Zachary A Bornholdt; Alexander S Krois; Ian A Wilson; Erica Ollmann Saphire
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

3.  Ezrin-anchored protein kinase A coordinates phosphorylation-dependent disassembly of a NHERF1 ternary complex to regulate hormone-sensitive phosphate transport.

Authors:  Bin Wang; Chris K Means; Yanmei Yang; Tatyana Mamonova; Alessandro Bisello; Daniel L Altschuler; John D Scott; Peter A Friedman
Journal:  J Biol Chem       Date:  2012-05-24       Impact factor: 5.157

4.  Effects of pH and ionic strength on the thermodynamics of human serum albumin-photosensitizer binding.

Authors:  Cecil L Jones; Tireje Dickson; Ronald Hayes; Lana Thomas
Journal:  Thermochim Acta       Date:  2012-10-10       Impact factor: 3.115

5.  Molecular dynamics studies of a hexameric purine nucleoside phosphorylase.

Authors:  Fernando Berton Zanchi; Rafael Andrade Caceres; Rodrigo Guerino Stabeli; Walter Filgueira de Azevedo
Journal:  J Mol Model       Date:  2009-08-11       Impact factor: 1.810

6.  Molecular modeling and dynamics studies of purine nucleoside phosphorylase from Bacteroides fragilis.

Authors:  Ivani Pauli; Luis Fernando Saraiva Macedo Timmers; Rafael Andrade Caceres; Luiz Augusto Basso; Diógenes Santiago Santos; Walter Filgueira de Azevedo
Journal:  J Mol Model       Date:  2009-01-27       Impact factor: 1.810

7.  Effects of 2-amino-8-hydroxyquinoline interaction on the conformation of physiological isomers of human serum albumin.

Authors:  Sonali M Shiriskar; Neeraj Agarwal; Raghuvir R S Pissurlenkar; Basir Ahmad
Journal:  Eur Biophys J       Date:  2015-03-12       Impact factor: 1.733

8.  T-cell epitope prediction and immune complex simulation using molecular dynamics: state of the art and persisting challenges.

Authors:  Matthew N Davies; Darren R Flower; Kanchan Phadwal; Isabel K Macdonald; Peter V Coveney; Shunzhou Wan
Journal:  Immunome Res       Date:  2010-11-03

9.  Analysis of protein-ligand interactions by fluorescence polarization.

Authors:  Ana M Rossi; Colin W Taylor
Journal:  Nat Protoc       Date:  2011-03-03       Impact factor: 13.491

10.  Interaction of multimicrobial synthetic inhibitor 1,2-bis(2-benzimidazolyl)-1,2-ethanediol with serum albumin: spectroscopic and computational studies.

Authors:  Nayana Kamtekar; Anita Pandey; Neeraj Agrawal; Raghuvir R S Pissurlenkar; Mohanish Borana; Basir Ahmad
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.